144 related articles for article (PubMed ID: 28317890)
1. Meta-analysis of the changes of peripheral blood regulatory T cell to CD4
Deng C; Li W; Chen S; Li Y
Sci Rep; 2017 Mar; 7():43532. PubMed ID: 28317890
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Th17 cells and CD4⁺CD25⁺ regulatory T cells with clinical parameters in patients with systemic sclerosis.
Jiang N; Li M; Zeng X
Chin Med J (Engl); 2014; 127(20):3557-61. PubMed ID: 25316229
[TBL] [Abstract][Full Text] [Related]
3. The Regulatory T Cell in Active Systemic Lupus Erythematosus Patients: A Systemic Review and Meta-Analysis.
Li W; Deng C; Yang H; Wang G
Front Immunol; 2019; 10():159. PubMed ID: 30833946
[No Abstract] [Full Text] [Related]
4. Regulatory T Cells in Systemic Sclerosis.
Frantz C; Auffray C; Avouac J; Allanore Y
Front Immunol; 2018; 9():2356. PubMed ID: 30374354
[TBL] [Abstract][Full Text] [Related]
5. Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma.
Klein S; Kretz CC; Ruland V; Stumpf C; Haust M; Hartschuh W; Hartmann M; Enk A; Suri-Payer E; Oberle N; Krammer PH; Kuhn A
Ann Rheum Dis; 2011 Aug; 70(8):1475-81. PubMed ID: 21097800
[TBL] [Abstract][Full Text] [Related]
6. Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions.
Mathian A; Parizot C; Dorgham K; Trad S; Arnaud L; Larsen M; Miyara M; Hié M; Piette JC; Frances C; Yssel H; Amoura Z; Gorochov G
Ann Rheum Dis; 2012 Jul; 71(7):1227-34. PubMed ID: 22696687
[TBL] [Abstract][Full Text] [Related]
7. Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis.
Fenoglio D; Battaglia F; Parodi A; Stringara S; Negrini S; Panico N; Rizzi M; Kalli F; Conteduca G; Ghio M; De Palma R; Indiveri F; Filaci G
Clin Immunol; 2011 Jun; 139(3):249-57. PubMed ID: 21419712
[TBL] [Abstract][Full Text] [Related]
8. Meta-Analysis of Changes in the Number and Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis.
Li M; Zhou X; Zhou L; Yu Z; Fu L; Yang P
Biomed Res Int; 2020; 2020():8709804. PubMed ID: 32149142
[TBL] [Abstract][Full Text] [Related]
9. Increased microchimeric CD4+ T lymphocytes in peripheral blood from women with systemic sclerosis.
Artlett CM; Cox LA; Ramos RC; Dennis TN; Fortunato RA; Hummers LK; Jimenez SA; Smith JB
Clin Immunol; 2002 Jun; 103(3 Pt 1):303-8. PubMed ID: 12173305
[TBL] [Abstract][Full Text] [Related]
10. Role of cellular immunity in systemic sclerosis pathogenesis: update on CD4+T cells population studies.
Beşliu AN; Bănică LM; Lonescu R; Predeţeanu D; Stăvaru C; Marica CM; Chiţonu C; Pistol G; Stefănescu M; Matache C
Roum Arch Microbiol Immunol; 2009; 68(1):5-13. PubMed ID: 19507621
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity.
Slobodin G; Ahmad MS; Rosner I; Peri R; Rozenbaum M; Kessel A; Toubi E; Odeh M
Cell Immunol; 2010; 261(2):77-80. PubMed ID: 20096404
[TBL] [Abstract][Full Text] [Related]
12. Disease Manifestation and Inflammatory Activity as Modulators of Th17/Treg Balance and RORC/FoxP3 Methylation in Systemic Sclerosis.
Almanzar G; Klein M; Schmalzing M; Hilligardt D; El Hajj N; Kneitz H; Wild V; Rosenwald A; Benoit S; Hamm H; Tony HP; Haaf T; Goebeler M; Prelog M
Int Arch Allergy Immunol; 2016; 171(2):141-154. PubMed ID: 27902985
[TBL] [Abstract][Full Text] [Related]
13. Increased proportions of functionally impaired regulatory T cell subsets in systemic sclerosis.
Ugor E; Simon D; Almanzar G; Pap R; Najbauer J; Németh P; Balogh P; Prelog M; Czirják L; Berki T
Clin Immunol; 2017 Nov; 184():54-62. PubMed ID: 28522286
[TBL] [Abstract][Full Text] [Related]
14. Resting and Activated Natural Tregs Decrease in the Peripheral Blood of Patients with Atherosclerosis.
Yazdani M; Khosropanah S; Hosseini A; Doroudchi M
Iran J Immunol; 2016 Dec; 13(4):249-262. PubMed ID: 27999237
[TBL] [Abstract][Full Text] [Related]
15. DNA hypermethylation of the forkhead box protein 3 (FOXP3) promoter in CD4+ T cells of patients with systemic sclerosis.
Wang YY; Wang Q; Sun XH; Liu RZ; Shu Y; Kanekura T; Huang JH; Li YP; Wang JC; Zhao M; Lu QJ; Xiao R
Br J Dermatol; 2014 Jul; 171(1):39-47. PubMed ID: 24641670
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of Runx1 and lowered proportion of Foxp3⁺ CD25⁺ CD4⁺ regulatory T cells in systemic sclerosis.
Kataoka H; Yasuda S; Fukaya S; Oku K; Horita T; Atsumi T; Koike T
Mod Rheumatol; 2015 Jan; 25(1):90-5. PubMed ID: 24716598
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T Cells in Systemic Sclerosis: a Comprehensive Review.
Slobodin G; Rimar D
Clin Rev Allergy Immunol; 2017 Apr; 52(2):194-201. PubMed ID: 27318947
[TBL] [Abstract][Full Text] [Related]
18. Alpha4beta1 and alpha4beta7 CD4 T cell numbers increase and CLA CD4 T cell numbers decrease in systemic sclerosis.
Scala E; Paganelli R; Sampogna F; Abeni D; Colonna L; De Pità O; Puddu P; Russo G
Clin Exp Immunol; 2005 Mar; 139(3):551-7. PubMed ID: 15730402
[TBL] [Abstract][Full Text] [Related]
19. Percentage and function of CD4+CD25+ regulatory T cells in patients with hyperthyroidism.
Jiang TJ; Cao XL; Luan S; Cui WH; Qiu SH; Wang YC; Zhao CJ; Fu P
Mol Med Rep; 2018 Feb; 17(2):2137-2144. PubMed ID: 29207121
[TBL] [Abstract][Full Text] [Related]
20. Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis.
Hussein MR; Hassan HI; Hofny ER; Elkholy M; Fatehy NA; Abd Elmoniem AE; Ezz El-Din AM; Afifi OA; Rashed HG
J Clin Pathol; 2005 Feb; 58(2):178-84. PubMed ID: 15677539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
